Analyst Ratings for Par Pharmaceutical (PRX) [Buys]
PRX Rating Summary
PRX Price Target Summary
- Highest: $50.00 (ThinkEquity)
- Lowest: $34.00 (Goldman Sachs)
- Average: $41.80
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$41.80 (-16.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2011 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
N/A (N/A) |
29.33 | 49.98 | 70.41% | Details |
| 8/5/2010 | Caris & Co. | Upgrade | Buy (N/A) |
N/A (N/A) |
27.53 | 49.98 | 81.55% | Details |
